Insider · CIK 0001209522
RUBINSTEIN JONATHAN
director
Files at AMZN (AMAZON COM INC). First filing Nov 5, 2024, latest Dec 11, 2024.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 4
$0 bought, $4.0M sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Side | Company | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 28Weak | sell 210b5-1 | AMZN AMAZON COM INC | $1.0M | 4,351 | -5% | - | |
| 35Weak | sell 710b5-1 | AMZN AMAZON COM INC | $1.0M | 4,549 | -5% | - | |
| 35Weak | sell 1010b5-1 | AMZN AMAZON COM INC | $1.0M | 4,766 | -5% | - | |
| 35Weak | sell 410b5-1 | AMZN AMAZON COM INC | $1.0M | 5,004 | -5% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 9, 2024 | AMZN AMAZON COM INC | SOpen-market sale Common Stock, par value $.01 per share10b5-1 | -4,351 | $229.85 | $1.0M | 88,203 | Dec 11, 2024 |
| Dec 4, 2024 | AMZN AMAZON COM INC | SOpen-market sale Common Stock, par value $.01 per share10b5-1 | -4,549 | $219.85 | $1.0M | 92,554 | Dec 6, 2024 |
| Nov 15, 2024 | AMZN AMAZON COM INC | MOption exercise Common Stock, par value $.01 per share | +2,473 | $0.00 | $0 | 97,103 | Nov 19, 2024 |
| Nov 15, 2024 | AMZN AMAZON COM INC | MOption exercise Restricted Stock Unit Awardderivative | -2,473 | $0.00 | $0 | 2,473 | Nov 19, 2024 |
| Nov 7, 2024 | AMZN AMAZON COM INC | SOpen-market sale Common Stock, par value $.01 per share10b5-1 | -4,766 | $209.85 | $1.0M | 94,630 | Nov 12, 2024 |
| Nov 1, 2024 | AMZN AMAZON COM INC | SOpen-market sale Common Stock, par value $.01 per share10b5-1 | -5,004 | $199.85 | $1.0M | 99,396 | Nov 5, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.